Burden of Clostridium difficile on the healthcare system. - Wikidata - wikimedia - TriplyDB

Burden of Clostridium difficile on the healthcare system.

Burden of Clostridium difficile on the healthcare system.

http://www.wikidata.org/entity/Q36071497

about

Fecal microbiota transplantation: in perspective Recent Advances in the Diagnosis and Treatment of Clostridium Difficile Infection Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection Interactions Between the Gastrointestinal Microbiome and Clostridium difficile Optimizing Antibiotic Stewardship in Nursing Homes: A Narrative Review and Recommendations for Improvement Murine models to study Clostridium difficile infection and transmission Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection Host recognition of Clostridium difficile and the innate immune response.Structural and functional analysis of the CspB protease required for Clostridium spore germination The structure of the cysteine protease and lectin-like domains of Cwp84, a surface layer-associated protein fromClostridium difficile The potential for emerging therapeutic options for Clostridium difficile infection Nosocomial transmission of C. difficile in English hospitals from patients with symptomatic infection Chemical and Stress Resistances of Clostridium difficile Spores and Vegetative Cells Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections.An institutional comparison of total abdominal colectomy and diverting loop ileostomy and colonic lavage in the treatment of severe, complicated Clostridium difficile infections.The microbiota and immune response during Clostridium difficile infection.Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.Role of interleukin 23 signaling in Clostridium difficile colitis In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.Optimal screening and donor management in a public stool bank.Economics and financing of vaccines for diarrheal diseases The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms - an appraisal Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis.A high-throughput small-molecule screen to identify a novel chemical inhibitor of Clostridium difficile.Recovery of the gut microbiome following fecal microbiota transplantation.Epidemiology of Clostridium difficile infection Prevalence and risk factors for asymptomatic Clostridium difficile carriage.Initiation of sporulation in Clostridium difficile: a twist on the classic model Multistate point-prevalence survey of health care-associated infections Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.Modelling the transmission of healthcare associated infections: a systematic review.Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations Metronidazole-induced encephalopathy after prolonged metronidazole course for treatment of C. difficile colitis.Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract

P2860

Q26765214-88E28CD9-C7A6-4FD8-82A4-A30F0313DA26 Q26766112-75DA3FC8-21EE-4505-B0B1-D0E50AF108D5 Q26767079-65FF175F-17A7-490A-B52D-74ABA82AA6A6 Q26778722-BF2D8D1F-EE96-4290-AD36-EE344BD5C785 Q26796478-5C22620E-D883-4A42-8911-FB5F577D5AA1 Q26859965-484C85D7-ADB3-4FFB-A30D-1A097FCABF2E Q26995670-22789D23-B55A-4412-8E48-F083E42E1A69 Q26996462-306B5470-239C-44BF-9551-D76A2CBFFBA4 Q27026464-E1A9D3A3-80B5-4343-B9D5-A75E48EEC68A Q27676376-7973DC82-D653-4D10-B434-057B82CA876C Q27684602-8DECAA97-D5B1-4961-A879-1EB5F3CE8A51 Q28082059-5F07B940-1F0E-4BD0-A1ED-A0D28FA76058 Q28658118-3F85E135-E17E-4158-B459-AAAF1ACD1884 Q28821061-0897F62A-C70D-4455-BA9E-20D24B60259F Q30066419-7A5EF37D-97A3-47A3-8B0B-0E5F0D1E3368 Q30251941-AEFB7059-10F4-4295-BA39-8454910EFAAA Q30275242-CA455D9A-6D35-40F9-A909-566A285CB724 Q30276756-91F80D50-7221-4A20-8574-4A5A77124C8B Q30277264-D2A0B00C-4A8F-45C6-88EB-013DF5C3020A Q30410725-040BC6B5-7099-42DD-B67A-DA1D3FA8560C Q30414030-02A21B20-975F-4393-92CF-A535C485C29D Q30834661-9D01C510-5382-48EF-971F-73C48CD9D845 Q31105341-3F4A8DCD-D7B5-43C5-8D62-0191AB7DD6AA Q33457821-5F3E8393-372F-4FE4-AD27-2E32649DBA19 Q33578052-375B93FE-55E5-4749-B5BB-3D04B1E56936 Q33662740-056D191A-5A7D-4AA2-B3A6-97FCFDC01009 Q33728333-4C719FB4-E233-447C-B95F-37E6163931B9 Q33767958-DC7CC6CD-01C7-4FA9-B245-1DD3142A7F3A Q33774194-D656D7DB-90EA-4294-8B86-2871CFF1406B Q33797312-30D895C8-01D4-4203-9951-F71A81512A2F Q34027474-D8B5641C-B3D6-48B2-BEED-1E03E048D701 Q34048138-FE90CD9F-792B-486A-833B-1D042EC0FD29 Q34306985-79918314-C5BE-495A-A3BD-B75E3061624C Q34412128-96EABD25-008F-4B25-8CE1-B06E6C864DB7 Q34649546-501708BB-DEF4-48AB-9C24-42CC6100908A Q34786520-6866E1C1-5771-4283-9EFB-5EEC4E416914 Q34801846-DC1D9A8D-9692-499B-9AAC-44026DCC3F8A Q35015788-AD44E3B2-E7D5-487E-A019-2FECE19CACBB Q35076948-2353E99E-170C-4526-8DEB-306E0A570836 Q35098142-A84FF548-FD59-4F3F-A17C-B7684B1EEDF2

P2860

Burden of Clostridium difficile on the healthcare system.

http://www.wikidata.org/entity/Q36071497

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Burden of Clostridium difficile on the healthcare system.

@ast

Burden of Clostridium difficile on the healthcare system.

@en

type

label

Burden of Clostridium difficile on the healthcare system.

@ast

Burden of Clostridium difficile on the healthcare system.

@en

prefLabel

Burden of Clostridium difficile on the healthcare system.

@ast

Burden of Clostridium difficile on the healthcare system.

@en

P1433

Q36071497-419B3383-8673-4C92-891F-36ACE003E93A

P1476

Q36071497-D3767C94-36A3-4B72-9251-FB81AA239E96

P2093

Q36071497-858753B0-6387-41FC-95C7-E9FE2E302268

P275

Q36071497-E064BEB4-9389-49A5-8DFE-2A37874C010C

P2860

Q36071497-014A89BE-1698-45CD-8AF0-C083D82C16E5

Q36071497-1094AFCA-FEB2-44BF-9EA5-B82C1FC2A121

Q36071497-166A754C-B8DD-44D1-8285-57626E5E694F

Q36071497-376E5969-BCEE-4B43-B9F6-6D4934C736B7

Q36071497-3DE54A7C-DA28-4BEE-9956-492EA2009165

Q36071497-63B3D4E0-E524-4CDD-9BCC-0F193B313C68

Q36071497-676AC96F-7C20-4348-B1E2-26AC19149DD5

Q36071497-6B13A500-64E8-45B8-A1E9-9D591175F55B

Q36071497-7623FBCA-DD00-4986-AED8-6B5DCD8B8411

Q36071497-8BCB57C7-EF68-4F75-AB90-9D6BF3E81A63

P304

Q36071497-3CFCBA7C-5014-475C-BD92-5093257D022B

P31

Q36071497-047968AB-6D0C-4EEB-9E99-95057E00D93F

Q36071497-CCA381F8-ABA9-4D60-98D2-5287A36421FA

P356

Q36071497-0FC28EAA-6083-4CD3-9F36-D08EF8F78F89

P407

Q36071497-2BB4AD48-DBA3-4C92-96C5-E8503B438EC3

P478

Q36071497-8F7F5667-43DD-451A-8455-4914D1DAE8C2

P50

Q36071497-8FC675E2-3F56-4DB8-B4EB-E6F2AF7F6199

P577

Q36071497-2FCEB773-B648-4DCA-BE91-40560A41A5FC

P5875

Q36071497-B9625011-24C0-4D7C-91CA-4637BDC7B18E

P698

Q36071497-7EEF9FD1-9548-4B17-BBC1-BDA68B59DEC8

P921

Q36071497-58B018AC-7D00-47D6-BEA4-77BCE76F2A64

Q36071497-FE0ADD6D-2D14-4C5D-ACFC-B7CFEEFFDBF0

P932

Q36071497-3DC562B0-5E12-4ABB-80AF-441BB1FD08DD

P356

P1433

Clinical Infectious Diseases

P1476

Burden of Clostridium difficile on the healthcare system.

@en

P2093

Margaret A Olsen

http://www.w3.org/2001/XMLSchema#string

P275

P2860

Matching methods for causal inference: A review and a look forward

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Treatment with monoclonal antibodies against Clostridium difficile toxins.

Fidaxomicin versus vancomycin for Clostridium difficile infection.

A case-control study of patient, medication, and care-related risk factors for inpatient falls.

Multicenter study of Clostridium difficile infection rates from 2000 to 2006

Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients.

Commentary: preventing Clostridium difficile-associated disease: is it time to pay the piper?

Review of current literature on the economic burden of Clostridium difficile infection.

Economic healthcare costs of Clostridium difficile infection: a systematic review.

P304

S88-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIS335

http://www.w3.org/2001/XMLSchema#string

P407

P478

55 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

Erik R Dubberke

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228328994

http://www.w3.org/2001/XMLSchema#string

P698

22752870

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

3388018

http://www.w3.org/2001/XMLSchema#string